4//SEC Filing
Johnson David Michael 4
Accession 0000950170-25-087890
CIK 0001501796other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:10 PM ET
Size
9.9 KB
Accession
0000950170-25-087890
Insider Transaction Report
Form 4
Johnson David Michael
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-17+17,000→ 17,000 totalExercise: $6.18Exp: 2035-06-17→ Common Stock (17,000 underlying) - Award
Common Stock
2025-06-17+13,000→ 179,167 total
Holdings
- 139,672(indirect: By Velocity Capital Management)
Common Stock
- 75,000(indirect: By Trust)
Common Stock
- 75,000(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.
- [F2]The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
- [F3]The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
- [F4]Velosity Capital Management LLC is an entity that the Reporting Person is the sole member of.
- [F5]This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001808098
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 4:10 PM ET
- Size
- 9.9 KB